L. Phee

发表

J. Mehta, N. Sharma, Hon Shing Ong, 2021, The ocular surface.

Optimal detection of carbapenemase-producing Enterobacteriaceae from rectal samples: a role for enrichment?

D. Wareham, M. Wilks, B. Cherian, 2017, The Journal of hospital infection.

In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens

D. Wareham, M. Hornsey, L. Phee, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.

Amir S. Sharili, D. Wareham, L. Phee, 2015, Journal of natural products.

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.

D. Wareham, J. Standing, M. Hornsey, 2019, The Journal of antimicrobial chemotherapy.

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

D. Wareham, L. Phee, J. Betts, 2015, Antimicrobial Agents and Chemotherapy.

Understanding emergence of antimycobacterial dose dependent resistance

A. Witney, N. Stoker, F. Kloprogge, 2022, bioRxiv.

Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam.

D. Wareham, A. Liakopoulos, L. Phee, 2017, Journal of global antimicrobial resistance.

Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices

D. Wareham, L. Phee, M. H. F. Abdul Momin, 2018, The Journal of antimicrobial chemotherapy.

In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens

D. Wareham, M. Hornsey, C. Longshaw, 2012, Antimicrobial Agents and Chemotherapy.

Gram-Negative Bacterial Pathogens Combination with Colistin versus Activity of Telavancin in In Vitro

D. Wareham, M. Hornsey, C. Longshaw, 2012 .

Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital outbreak

D. Mack, Y. Carter, L. Phee, 2020, Infection prevention in practice.

Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia

N. Woodford, D. Wareham, L. Phee, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom

D. Wareham, M. Hornsey, L. Phee, 2011, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae

N. Woodford, D. Wareham, M. Hornsey, 2014, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii

D. Wareham, F. Kloprogge, J. Standing, 2019, The Journal of antimicrobial chemotherapy.

In vivo efficacy of telavancin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection.

D. Wareham, M. Hornsey, C. Longshaw, 2013, International journal of antimicrobial agents.

Enterobacteriaceae against Carbapenem-Resistant Therapies Tigecycline-Colistin Combination Activities of In Vivo and In Vitro

D. Wareham, M. Hornsey, L. Phee, 2014 .

In vitro and in vivo activity of ML302F: a thioenolate inhibitor of VIM-subfamily metallo β-lactamases

C. Schofield, D. Wareham, J. Brem, 2016 .

In vitro activity of the novel monosulfactam BAL30072 alone and in combination with meropenem versus a diverse collection of important Gram-negative pathogens.

D. Wareham, M. Hornsey, L. Phee, 2013, International journal of antimicrobial agents.

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis

A. Witney, N. Stoker, F. Kloprogge, 2022, Scientific reports.

Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract?

D. Wareham, L. Phee, J. Betts, 2016, Journal of global antimicrobial resistance.

Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase

N. Woodford, J. Turton, D. Wareham, 2013, Journal of Clinical Pathology.

Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae

D. Wareham, David W. Wareham, Rishita Shah, 2015, Journal of Clinical Microbiology.

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting

D. Manissero, F. Kloprogge, J. Standing, 2021, The Journal of antimicrobial chemotherapy.

Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections-authors' response.

D. Wareham, J. Standing, M. Hornsey, 2020, The Journal of antimicrobial chemotherapy.

CHROMagar COL‐APSE: a selective bacterial culture medium for the isolation and differentiation of colistin‐resistant Gram‐negative pathogens

R. Hendriksen, D. Wareham, M. Haenni, 2017, Journal of medical microbiology.

Carbapenemase-producing organism (CPO) colonisation at a district general hospital: universal screening may help reduce transmission

L. Phee, Binutha Bharathan, A. Sivaramakrishnan, 2021, Infection prevention in practice.

Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides

D. Wareham, L. Phee, J. Betts, 2018, Journal of medical microbiology.

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability

C. Schofield, D. Wareham, J. Brem, 2014, The Journal of antimicrobial chemotherapy.

Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.

D. Wareham, D. Mevius, A. Liakopoulos, 2016, Microbial drug resistance.

In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens

D. Wareham, M. Hornsey, L. Phee, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

In Vitro and In Vivo Activities of Tigecycline-Colistin Combination Therapies against Carbapenem-Resistant Enterobacteriaceae

N. Woodford, D. Wareham, M. Hornsey, 2014, Antimicrobial Agents and Chemotherapy.